Confluence Wealth Services Inc. Reduces Stock Position in UnitedHealth Group Incorporated $UNH

Confluence Wealth Services Inc. cut its position in UnitedHealth Group Incorporated (NYSE:UNH) by 5.1% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,101 shares of the healthcare conglomerate’s stock after selling 379 shares during the quarter. Confluence Wealth Services Inc.’s holdings in UnitedHealth Group were worth $2,215,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also bought and sold shares of the company. Duncan Williams Asset Management LLC raised its holdings in shares of UnitedHealth Group by 45.3% during the 2nd quarter. Duncan Williams Asset Management LLC now owns 4,246 shares of the healthcare conglomerate’s stock valued at $1,325,000 after buying an additional 1,324 shares in the last quarter. Appleton Partners Inc. MA boosted its holdings in UnitedHealth Group by 36.5% in the second quarter. Appleton Partners Inc. MA now owns 50,378 shares of the healthcare conglomerate’s stock valued at $15,717,000 after acquiring an additional 13,458 shares in the last quarter. PUREfi Wealth LLC boosted its position in UnitedHealth Group by 138.9% during the 2nd quarter. PUREfi Wealth LLC now owns 1,653 shares of the healthcare conglomerate’s stock valued at $516,000 after acquiring an additional 961 shares in the last quarter. Sendero Wealth Management LLC increased its stake in shares of UnitedHealth Group by 76.2% in the 2nd quarter. Sendero Wealth Management LLC now owns 6,239 shares of the healthcare conglomerate’s stock worth $1,946,000 after acquiring an additional 2,699 shares in the last quarter. Finally, Valeo Financial Advisors LLC increased its position in UnitedHealth Group by 1,726.1% during the 2nd quarter. Valeo Financial Advisors LLC now owns 253,360 shares of the healthcare conglomerate’s stock valued at $79,041,000 after buying an additional 239,486 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the company. JPMorgan Chase & Co. reduced their price objective on UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating for the company in a report on Wednesday, August 6th. Barclays increased their price objective on shares of UnitedHealth Group from $337.00 to $352.00 and gave the stock an “overweight” rating in a research note on Thursday, September 4th. Oppenheimer dropped their target price on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a research report on Wednesday, July 30th. Weiss Ratings reiterated a “sell (d+)” rating on shares of UnitedHealth Group in a research report on Saturday, September 27th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $440.00 price target on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Sixteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and four have given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $358.95.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $360.17 on Monday. The company has a market cap of $326.20 billion, a PE ratio of 15.61, a P/E/G ratio of 2.34 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The business has a 50-day simple moving average of $307.84 and a two-hundred day simple moving average of $353.45. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. During the same period in the prior year, the firm posted $6.80 EPS. The firm’s revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.